Leona Reilly

Trascinare per riposizionare la copertura

Leona Reilly

Detagli
7 messaggi
Femmina
11/30/-1
Residente a Stati Uniti

Foto

nuovo articolo creato

Tradurre 10 w

Cost-effective Animal Disease Models to Power Up Life Science Research | #animal models

Cost-effective Animal Disease Models to Power Up Life Science Research

A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released.

Mi piace

Commento

640

nuovo articolo creato

Tradurre 10 w

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform | # CAR-T cell therapy services

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform

Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.

Mi piace

Commento

640

nuovo articolo creato

Tradurre 13 w

Protheragen Advances Cell-Based Models Development Service | #cell-Based Models Development Service

Protheragen Advances Cell-Based Models Development Service

Cell-based model is a crucial tool widely used in the early stage of drug development, which is a generalized modular approach to simulate the disease pathogenesis and detect drug response in vitro in biomedical research of rare diseases.

Mi piace

Commento

640

nuovo articolo creato

Tradurre 13 w

Protheragen Advances Research Solutions for Rare Cancers | #rare Cancers

Protheragen Advances Research Solutions for Rare Cancers

Protheragen, a leading biotechnology company specializing in innovative research solutions, announces its comprehensive service portfolio dedicated to rare cancers, addressing the unique challenges these uncommon malignancies present to the medical community and affected patients worldwide

Mi piace

Commento

640

nuovo articolo creato

Tradurre 17 w

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease | #systemic Mitochondrial Disease

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease

Protheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease. The company's specialized services address the complex

Mi piace

Commento

640

Carica piu notizie

Foto

Tradurre 10 w

Cost-effective Animal Disease Models to Power Up Life Science Research

Tradurre 10 w

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform

Tradurre 13 w

Protheragen Advances Cell-Based Models Development Service

Tradurre 13 w

Protheragen Advances Research Solutions for Rare Cancers

Tradurre 17 w

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease

Following 0

Followers 0

Mi piace 0

Gruppi 0